RGC 5.87 (+3.89%)
KYG7487R1002Drug ManufacturersDrug Manufacturers - Specialty & Generic

Regencell Bioscience Holdings (RGC) Competitor Comparison

We are evaluating the key criteria listed to compare Regencell Bioscience Holdings (RGC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Total Rank - RGC ranking 15 / 54

These are the competitors of Regencell Bioscience Holdings in the industry Drug Manufacturers - Specialty & Generic ranked by total rank
1. ProPhase Labs PRPH
4
2. Embecta EMBC
4
3. Vifor Pharma G2AB.F
4
4. Teva Pharmaceutical Industries TEVA
3
5. Eagle Pharmaceuticals EGRX
3
6. Elanco Animal Health ELAN
3
7. Linc LNC
3
8. Catalent CTLT
3
9. Organogenesis Holdings ORGO
3
10. Amneal Pharmaceuticals AMRX
3
11. Perrigo PRGO
3
12. PetIQ PETQ
3
13. Phibro Animal Health PAHC
3
14. Procaps Group PROC
3
15. Regencell Bioscience Holdings RGC
3
16. Green Thumb Industries R9U2.F
3
17. Taro Pharmaceutical Industries TARO
3
18. Amphastar Pharmaceuticals AMPH
3
19. Cumberland Pharmaceuticals CPIX
3
20. Kolinpharma KIP.MI
2
21. Neoleukin Therapeutics NLTX
2
22. OptiNose OPTN
2
23. Pacira BioSciences PCRX
2
24. Zynerba Pharmaceuticals ZYNE
2
25. Alpha Teknova TKNO
2
26. Alvotech ALVO
2
27. ANI Pharmaceuticals ANIP
2
28. Ascend Wellness Holdings AAWH
2
29. Ayr Wellness 3KJB.F
2
30. Bausch Health Companies BHC
2
31. Clever Leaves Holdings CLVR
2
32. Collegium Pharmaceutical COLL
2
33. Cronos Group CRON
2
34. Curaleaf Holdings CURLF
2
35. Emergent BioSolutions EBS
2
36. Evolus EOLS
2
37. Flora Growth FLGC
2
38. Harrow Health HROW
2
39. Ironwood Pharmaceuticals IRWD
2
40. Journey Medical DERM
2
41. Jupiter Wellness JUPW
2
42. Kamada KMDA
2
43. Tilray Brands TLRY
2
44. Universe Pharmaceuticals UPC
2
45. Zoetis ZTS
2
46. Alimera Sciences ALIM
2
47. Societal CDMO SCTL
2
48. Solid Biosciences SLDB
2
49. Supernus Pharmaceuticals SUPN
2
50. Theratechnologies THTX
2
51. SCYNEXIS SCYX
1
52. Relmada Therapeutics RLMD
1
53. Biofrontera BFRI
1
54. Avadel Pharmaceuticals AVDL
1

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.